25 LLC’s Eli Lilly LLY Stock Holding History

25 LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$484K	Buy	526 +63	+14%	+$63.9K	0.15%	40
2025 Q4	$498K	Buy	463 +139	+43%	+$133K	0.16%	42
2025 Q3	$247K	Buy	324 +2	+0.6%	+$1.49K	0.08%	59
2025 Q2	$251K	Sell	322 -4	-1%	-$3.11K	0.09%	56
2025 Q1	$269K	Buy	326 +21	+7%	+$17.5K	0.11%	49
2024 Q4	$235K	Buy	305 +46	+18%	+$38.1K	0.1%	50
2024 Q3	$229K	Buy	259 +8	+3%	+$7.19K	0.1%	51
2024 Q2	$227K	Buy	+251	New	+$201K	0.11%	46
2023 Q3	–	Sell	-8	Closed	-$3.48K	–	308
2023 Q2	$3.48K	Buy	8 +3	+60%	+$1.26K	﹤0.01%	192
2023 Q1	$2.16K	Buy	+5	New	+$1.69K	﹤0.01%	206

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

25 LLC's LLY Position: Q1 2026 in Review

25 LLC increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $63.9K and bringing the position to 526 shares worth $484K. The position accounts for 0.15% of the portfolio, ranked #40.

25 LLC first reported a position in LLY in Q1 2023 and has held it in 10 quarters since. The position peaked at $498K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

25 LLC held 526 shares of Eli Lilly worth $484K as of Q1 2026.
25 LLC bought 63 Eli Lilly shares in Q1 2026, an estimated $63.9K.
Eli Lilly made up 0.15% of 25 LLC's portfolio in Q1 2026, its #40 holding.
25 LLC first reported a position in Eli Lilly in Q1 2023 and has held it in 10 quarters since.
25 LLC's Eli Lilly position peaked at $498K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 25 LLC's 13F filing for Q1 2026, filed 20 Apr 2026.